The company mainly produces plant raw materials and various preparations, and is the largest plant raw material extraction base in Shandong Province. Guided by product development, the company has its own scientific research institute and unique professional technology, and jointly develops high-quality, refined and sophisticated products with domestic universities and scientific research institutions, forming a product series of more than 90 varieties 1 1 kinds of raw materials, such as Pulelin, Oberland, Qige Tongmai, Jiejing, Troxerutin, etc. The leading product, Pulelin Injection, has successively won the titles of products recommended by Chinese Pharmaceutical Association, products trusted by consumers in China and Yantai famous brand products. The company's extraction technology is at the leading level in China, especially the monomer separation technology, in which the purity of puerarin is over 97% and the production technology of troxerutin has reached the leading level in China.
First-class management has always been the goal pursued by Luyin Pharmaceutical. The company has extensively absorbed advanced management experience at home and abroad, successfully introduced CIS corporate image strategy and advanced computer information management system, and established a modern management system adapted to the development of Luyin medicine. The company has a modern preparation workshop that has passed GMP certification and a perfect ISO9000 quality certification system.
The perfect marketing mechanism provides a broad development space for Luyin Pharmaceutical Industry. The company has three sales regions and six sales business districts in China, and the high-level marketing network is spread all over the country.
Adhering to the enterprise tenet of all for health, the company will further expand the field of drug development, accelerate the development of enterprises, and move forward to the first-class modern pharmaceutical group company with strong vitality and market competitiveness in China!
The sea is wide and the fish jumps, and the sky is high and birds fly. The company will provide broad development space and professional training opportunities for outstanding talents. Welcome people of insight to join us, and step into glory with the company. Company's main products:
Vinblastine sustained-release capsules
Nifuratel
Puerarin injection
Moisturizing adjustable nasal cavity cleaner
Scopolamine butylbromide injection
Troxerutin injection
Qigetongmai Granule
Fluconazole capsules
Sinidipine
Zantinol nicotinate injection
Propranolol (paracetamol dispersible tablets)
Acetylglutamine injection
Procon? Lysine hydrochloride and sodium chloride injection
Cigna? Puerarin injection
Lin Shu? Vinpocetine and glucose injection
Nefopam hydrochloride injection hydrochloride
Mefenamic acid capsules
Paracetamol aspirin injection ...
Contact information: Send your resume directly to this website.
Thank you for your cooperation!
Legal Representative: Wang Jun.
Date of establishment: 1993- 12-20.
Registered capital: 654.38+032.074 million yuan.
Location: Shandong Province
Unified social credit code: 9137060013415452l.
Business status: in-service (opened) enterprises.
Industry: manufacturing industry
Company type: limited liability company (wholly owned by a legal person invested or controlled by a natural person)
English name: Yantai Luyin Pharmaceutical Co., Ltd.
Number of employees: 100-499.
Enterprise address: No.0/02, Baishi Road, Yantai City, Shandong Province
Business scope: production of small-volume injections (including hormones), tablets, hard capsules, soft capsules, granules, fluid extracts, tinctures, ointments, raw materials and pharmaceutical excipients; Production of Class II 6854 operating room, emergency room and outpatient equipment and appliances (the validity period is subject to the license); Production of traditional Chinese medicine extracts; Import and export of goods and technologies; Lease of self-owned houses; Research and development, technical consultation, technical service and technology transfer of medicine and biotechnology; Research and development of biological products, drugs, health care products and medical devices. (Projects subject to approval according to law can only be operated after approval by relevant departments)